Prot #XPORT-GBM-029: A Phase 1/2 Study of Selinexor in Combination with Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma

Project: Research project

Project Details

StatusActive
Effective start/end date11/3/20 → 11/3/23

Funding

  • ICON Clinical Research, LLC (Prot #XPORT-GBM-029)
  • Karyopharm Therapeutics Inc. (Prot #XPORT-GBM-029)
View all
View less